EPL LtdQ1 FY27
EPL Ltd Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹252P/E: 20.7Market Cap: ₹8.5K CrSector: Industrial Products
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
Yes
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- →EPL Limited raised its revenue growth guidance to high teens from low double digits for the coming quarters, reflecting strong momentum.
- →Continued strong growth in Beauty & Cosmetics (B&C) category with potential to double market share from 8% to 16% over the next few years.
- →Oral Care category has shown a significant recovery and growth above 20%.
- →Underlying revenue growth (excluding Middle East pricing impact) was 20% this quarter.
- →Volume growth is strong but influenced by product mix and pricing differences across categories and countries.
- →Expansion into new markets like Thailand and investments in emerging markets such as Southeast Asia and Africa through the Indovida merger.
- →Long-term vision includes expanding beyond tubes into newer, higher-growth packaging formats.
- →Investment in innovation, sales capabilities, and capacity expansion to sustain growth momentum.
Margin guidance
Category 3- →Full-year PAT expected to deliver double-digit growth despite Q1 PAT dip due to tax rate impact.
- →PBT increased by 10% in Q1 and expected to sustain growth momentum for the full year.
- →EBITDA growth raised guidance to high teens with a maintained underlying margin guidance of ~20%.
- →Investments in capabilities and capacity (especially in Beauty & Cosmetics and key geographies like Thailand) expected to drive sustained revenue and profit growth.
- →Post-merger with Indovida, EPS is anticipated to be accretive due to strong PAT alignment between companies.
- →Americas and Europe margins to improve over coming quarters upon normalization of investments and operational efficiencies.
- →Long-term focus on innovation, sustainability, and expanding into higher-growth packaging formats to support profitable growth.
- →Overall confident in sustainable, profitable growth and margin retention amid volatile environment.
Fundraise plans
The transcript does not mention any current or future plans for fundraising through debt or equity. Key points related to financing:
- Net debt has increased due to inventory buildup and ahead-of-curve CapEx investments.
- The company emphasizes disciplined capital allocation and strong capital efficiency.
- Focus remains on sustaining margins and profitable growth without indicating additional fundraising.
- No explicit mention of planned new debt or equity issuance in the call.
- Merger with Indovida is in approval process, expected to enhance growth but no financing details shared.
- Operating and investment expenses are aligned with growth strategy, managed internally.
Hence, based on the provided transcript, EPL Limited has no disclosed plans for new debt or equity fundraising at this time.
Order book
YesThe provided transcript does not explicitly mention the current or expected order book or pending orders for EPL Limited. However, the following related insights can be noted:
- The company is seeing strong demand momentum across categories, especially in Beauty & Cosmetics, with potential to double market share in coming years.
- Management highlights promising sales pipeline in Europe due to investments in capacity and capabilities.
- Investments and capacity expansions indicate preparation for higher future demand.
- The merger with Indovida, once approved, is expected to be EPS accretive and likely to enhance business scale.
- Overall, the company expresses confidence in sustained growth driven by broad-based demand and strategic investments.
No specific numerical details or direct commentary on order book or pending orders are provided in the transcript.
Capex plans
Yes- EPL Limited is making significant proactive growth investments ahead of the curve in key strategic areas, including both opex and capex.
- Investments include setting up a full-service center of excellence for Beauty & Cosmetics (B&C) in India.
- The sales team has been divisionalized with separate teams for B&C and Oral care to better serve these segments.
- Capex investments are made ahead of the growth curve to be ready for additional demand.
- In Europe, investments are focused on expanding capacities for extruded tubes, printing, and Beauty & Cosmetics capabilities like die and tooling.
- Investments in the Americas involve both operating and capex to enhance capabilities in Brazil and the U.S., including outsourcing specialized items for Beauty & Cosmetics.
- Thailand operations, a significant B&C market, are beginning to ramp up, contributing to growth.
- EPL is actively scouting for acquisitions that help move into new formats or markets aligned with growth and margin objectives.
Overall, EPL maintains capital discipline while investing to support high-teens growth and margin targets.
Track EPL Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- →Full-year PAT expected to deliver double-digit growth despite Q1 PAT dip due to tax rate impact.
- →PBT increased by 10% in Q1 and expected to sustain growth momentum for the full year.
- →EBITDA growth raised guidance to high teens with a maintained underlying margin guidance of ~20%.
- →Investments in capabilities and capacity (especially in Beauty & Cosmetics and key geographies like Thailand) expected to drive sustained revenue and profit growth.
- →Post-merger with Indovida, EPS is anticipated to be accretive due to strong PAT alignment between companies.
- →Americas and Europe margins to improve over coming quarters upon normalization of investments and operational efficiencies.
- →Long-term focus on innovation, sustainability, and expanding into higher-growth packaging formats to support profitable growth.
- →Overall confident in sustainable, profitable growth and margin retention amid volatile environment.
Order book
YesThe provided transcript does not explicitly mention the current or expected order book or pending orders for EPL Limited. However, the following related insights can be noted:
- The company is seeing strong demand momentum across categories, especially in Beauty & Cosmetics, with potential to double market share in coming years.
- Management highlights promising sales pipeline in Europe due to investments in capacity and capabilities.
- Investments and capacity expansions indicate preparation for higher future demand.
- The merger with Indovida, once approved, is expected to be EPS accretive and likely to enhance business scale.
- Overall, the company expresses confidence in sustained growth driven by broad-based demand and strategic investments.
No specific numerical details or direct commentary on order book or pending orders are provided in the transcript.
How does EPL Ltd rank vs peers in Industrial Products?
Pro feature1EPL Ltd
Rev 3Mar 3
See full Industrial Products sector rankings
How does EPL Ltd rank in Industrial Products?
Compare EPL Ltd against every Industrial Products company (Q1 FY27) on revenue, margins and earnings-call signals.